Emergency use of COVID-19 vaccines recommended by the World Health Organization (WHO) as of June 2021

Author:

Cui Xiaoni1,Wang Pengxiang1,Wei Zhun2

Affiliation:

1. Sino-Cell Biomed Co., Ltd., Qingdao, Shandong, China.

2. Institute of Innovative Drugs and Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Reference25 articles.

1. 1. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who. int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (accessed March 11, 2021).

2. 2. Huang Q, Yan J. SARS-CoV-2 virus: Vaccines in development. Fundam Res. 2021; 1:131-138.

3. 3. Dai L, Gao GF. Viral targets for vaccines against COVID-19. Nat Rev Immunol. 2021; 21:73-82.

4. 4. Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process. WHO. https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_16June2021.pdf (accessed June 16, 2021).

5. 5. mRNA vaccines to address the COVID-19 pandemic. https://biontech.de/covid-19-portal/mrna-vaccines (accessed June 16, 2021).

Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3